文献速递真菌感染艾滋病与性传播感染

接受脂质体两性霉素B治疗的艾滋病合并播散性组织胞浆菌病患者组织胞浆菌真菌负荷动态变化

Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B.
PubMed 文献 · Clin Microbiol Infect · 2024-12-06

研究基于巴西一项比较三种脂质体两性霉素B方案的II期试验,对105例艾滋病合并播散性组织胞浆菌病患者系列血标本(n=325)行RT-qPCR定量全核酸检测。基线RT-qPCR阳性率64.2%(63/98),确诊感染患者中升至89%(47/53),尿抗原阳性率94.2%(97/103)。治疗期间WNA负荷斜率平坦(负荷升高)与第7天死亡相对风险8.6(p=0.046)及第12周相对风险3.3(p=0.008)相关,抗原斜率未见此关联(p>0.5)。

要点

  • 基线RT-qPCR阳性率64.2%(63/98),确诊感染患者中阳性率89%(47/53),尿抗原阳性率94.2%(97/103)。
  • 第7天或之后RT-qPCR仍阳性者初始WNA负荷更高(Cq=31[27-34] vs 阴性者Cq=38[33-40],p=0.001)。
  • WNA负荷斜率平坦与第7天死亡相对风险8.6(p=0.046)及第12周相对风险3.3(p=0.008)相关。

核心结论

  • 治疗期间组织胞浆菌WNA负荷斜率平坦(负荷升高)与第7天和第14天早期死亡相关。
  • 作者认为该诊断工具应在前瞻性试验中专门评估,以明确其识别预后较差患者并据此调整治疗的价值。

研究设计与样本

  • 研究基于巴西一项II期试验,该试验比较三种不同脂质体两性霉素B方案治疗艾滋病合并播散性组织胞浆菌病。
  • 对105例播散性组织胞浆菌病患者的系列血标本(n=325)行RT-qPCR检测,时间点为基线(第0天或第1天,D0/1)及抗真菌治疗期间(第3天D3;第4天或第5天D4/5;第7天D7;第14天D14)。

主要发现

  • D0/D1时RT-qPCR阳性率为64.2%(63/98),确诊感染患者中阳性率升至89%(47/53)。
  • 尿抗原在94.2%(97/103)的播散性组织胞浆菌病患者中阳性。
  • D7时或之后RT-qPCR阳性者初始WNA负荷更高(Cq=31[27-34]),而D7时RT-qPCR阴性者Cq=38[33-40](p=0.001)。
  • 三个治疗组间WNA负荷相当,三组RT-qPCR阳性患者百分比下降程度也相当。
  • WNA负荷斜率平坦(WNA负荷升高)与第7天死亡相对风险8.6(p=0.046)及第12周死亡相对风险3.3(p=0.008)相关;分析抗原斜率时未观察到该关联(p>0.5)。

临床怎么用

  • 作者认为该诊断工具应在前瞻性试验中专门评估,以明确其识别预后较差患者并据此调整治疗的价值。

局限性

  • 作者指出该诊断工具需在前瞻性试验中专门评估,以明确其识别预后较差患者并调整治疗的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Disseminated histoplasmosis (DH) is a lethal fungal disease in patients living with HIV in endemic regions of the world. Diagnosis relies mainly on microscopy, culture, and antigen detection. Our goal was to evaluate the diagnostic and prognostic role of our RT-quantitative PCR (RT-qPCR) in blood specimens allowing to quantify the whole nucleic acids (WNA) load. METHODS: We tested RT-qPCR assays on serial blood (n = 325) of 105 DH patients at baseline (day 0 or day 1, D0/1) and during antifungal therapy (day 3, D3; day 4 or day 5, D4/5; day 7, D7; and day 14, D14) collected from a phase II trial comparing three different regimens of liposomal amphotericin B for DH treatment in HIV patients from Brazil. RESULTS: The RT-qPCR was positive at D0/D1 in 64.2% (63/98) of the patients, but positivity increased to 89% (47/53) in patients with proven infection. Urine antigen was positive in 94.2% (97/103) of DH patients. RT-qPCR positive at or after D7 was significantly associated with higher initial WNA load (Cq = 31 [27-34]) when compared with RT-qPCR negative at D7 (Cq = 38 [33-40]) (p 0.001). The WNA load was equivalent in all treatment arms, and an equivalent decrease in the % of RT-qPCR-positive patients was observed in the three arms. Flat of negative WNA slope (increase of WNA load) was associated with an increased relative risk of death at D7 (relative risk, 8.6; p 0.046) and W12 (relative risk, 3.3; p 0.008). This association was not observed when analysing antigen slopes (p > 0.5). DISCUSSION: We found in this study an association between the progression of flat Histoplasma WNA load during treatment and early death at D7 and D14. This diagnostic tool should be evaluated specifically in a prospective trial to assess its usefulness in identifying patients with poorer prognosis and adapt their treatment accordingly.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Sturny-Leclère A, Da Silva E, Godoy CSM, et al. Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B. Clin Microbiol Infect. 2024. PMID: 39647811. doi:10.1016/j.cmi.2024.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。